These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24392816)

  • 1. Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research.
    Lakind JS; Goodman M; Mattison DR
    Crit Rev Toxicol; 2014 Feb; 44(2):121-50. PubMed ID: 24392816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature.
    Goodman M; Lakind JS; Mattison DR
    Crit Rev Toxicol; 2014 Feb; 44(2):151-75. PubMed ID: 24417397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphenol A, obesity, and type 2 diabetes mellitus: genuine concern or unnecessary preoccupation?
    Mirmira P; Evans-Molina C
    Transl Res; 2014 Jul; 164(1):13-21. PubMed ID: 24686036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programming of metabolic effects in C57BL/6JxFVB mice by exposure to bisphenol A during gestation and lactation.
    van Esterik JC; Dollé ME; Lamoree MH; van Leeuwen SP; Hamers T; Legler J; van der Ven LT
    Toxicology; 2014 Jul; 321():40-52. PubMed ID: 24726836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A.
    Andra SS; Charisiadis P; Arora M; van Vliet-Ostaptchouk JV; Makris KC
    Environ Int; 2015 Dec; 85():352-79. PubMed ID: 26521216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of environmental Bisphenol A exposure on breast cancer associated with obesity.
    Engin AB; Engin A
    Environ Toxicol Pharmacol; 2021 Jan; 81():103544. PubMed ID: 33161112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults.
    Lang IA; Galloway TS; Scarlett A; Henley WE; Depledge M; Wallace RB; Melzer D
    JAMA; 2008 Sep; 300(11):1303-10. PubMed ID: 18799442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to Bisphenol A and Bisphenol S and Incident Type 2 Diabetes: A Case-Cohort Study in the French Cohort D.E.S.I.R.
    Rancière F; Botton J; Slama R; Lacroix MZ; Debrauwer L; Charles MA; Roussel R; Balkau B; Magliano DJ;
    Environ Health Perspect; 2019 Oct; 127(10):107013. PubMed ID: 31663775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bisphenol A an environmental obesogen?
    Legeay S; Faure S
    Fundam Clin Pharmacol; 2017 Dec; 31(6):594-609. PubMed ID: 28622415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence.
    Rancière F; Lyons JG; Loh VH; Botton J; Galloway T; Wang T; Shaw JE; Magliano DJ
    Environ Health; 2015 May; 14():46. PubMed ID: 26026606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association between Bisphenol A Exposure and Obesity in Children-A Systematic Review with Meta-Analysis.
    Kim KY; Lee E; Kim Y
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31311074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphenol A: Targeting metabolic tissues.
    Chevalier N; Fénichel P
    Rev Endocr Metab Disord; 2015 Dec; 16(4):299-309. PubMed ID: 26820262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders.
    Stojanoska MM; Milosevic N; Milic N; Abenavoli L
    Endocrine; 2017 Mar; 55(3):666-681. PubMed ID: 27822670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol A, Hypertension, and Cardiovascular Diseases: Epidemiological, Laboratory, and Clinical Trial Evidence.
    Han C; Hong YC
    Curr Hypertens Rep; 2016 Feb; 18(2):11. PubMed ID: 26781251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A: an endocrine and metabolic disruptor.
    Fenichel P; Chevalier N; Brucker-Davis F
    Ann Endocrinol (Paris); 2013 Jul; 74(3):211-20. PubMed ID: 23796010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets of developmental exposure to bisphenol A in diabesity: a focus on endoderm-derived organs.
    Porreca I; Ulloa-Severino L; Almeida P; Cuomo D; Nardone A; Falco G; Mallardo M; Ambrosino C
    Obes Rev; 2017 Jan; 18(1):99-108. PubMed ID: 27776381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evidence of the association between monochlorinated bisphenol A exposure and type II diabetes mellitus: A pilot study.
    Andra SS; Kalyvas H; Andrianou XD; Charisiadis P; Christophi CA; Makris KC
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(3):243-59. PubMed ID: 25594118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concern about the Safety of Bisphenol A Substitutes.
    Moon MK
    Diabetes Metab J; 2019 Feb; 43(1):46-48. PubMed ID: 30793551
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis.
    Hwang S; Lim JE; Choi Y; Jee SH
    BMC Endocr Disord; 2018 Nov; 18(1):81. PubMed ID: 30400886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent exposure to Bisphenol-A increases anxiety and sucrose preference but impairs spatial memory in rats independent of sex.
    Diaz Weinstein S; Villafane JJ; Juliano N; Bowman RE
    Brain Res; 2013 Sep; 1529():56-65. PubMed ID: 23872220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.